Terns Pharmaceuticals, Inc.
TERNDelisted May 5, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831363
Terns Pharmaceuticals, Inc. was delisted on May 5, 2026; its insiders filed their last Form 4 on May 5, 2026; 317 institutions reported holding it in 13F filings for Q1 2026, worth $6.56B in total; Soros Fund Management was the only superinvestor holding it.
Superinvestors holding TERN, Q1 2026
1 superinvestor reports holding Terns Pharmaceuticals, Inc. on Form 13F, worth $17.0M in total. Weight is Terns Pharmaceuticals, Inc.'s share of each 13F portfolio; actions compare shares with Q4 2025.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Soros Fund ManagementGeorge Soros | 0.2% | 321,905 | $17.0M | New |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of TERN each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q1 2026
1 superinvestor holding at quarter end